Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders

The rare coagulation disorders may present significant difficulties in diagnosis and management. In addition, considerable inter‐individual variation in bleeding phenotype is observed amongst affected individuals, making the bleeding risk difficult to assess in affected individuals. The last international recommendations on rare inherited bleeding disorders (RIBDs) were published by the United Kingdom Haemophilia Centre Doctors' Organisation in 2014. Since then, new drugs have been marketed, news studies on surgery management in patients with RIBD have been published, and new orphan diseases have been described.

[1]  S. Madoiwa,et al.  A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder. , 2021, Blood advances.

[2]  James N. Huang,et al.  Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study , 2021, Research and practice in thrombosis and haemostasis.

[3]  M. Derwall,et al.  Coagulation management for a caesarean delivery in a mother with severe homozygous Factor V deficiency. , 2021, Journal of clinical anesthesia.

[4]  S. Susen,et al.  Clinical phenotype, fibrinogen supplementation and health-related quality of life in patients with afibrinogenemia. , 2021, Blood.

[5]  A. Biswas,et al.  Inhibitor in Congenital Factor VII Deficiency; a Rare but Serious Therapeutic Challenge—A Systematic Literature Review , 2021, Journal of clinical medicine.

[6]  B. Oukkache,et al.  Congenital Alpha-2 Antiplasmin Deficiency: a Literature Survey and Analysis of 123 Cases. , 2020, Clinical Laboratory.

[7]  S. Meunier,et al.  Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  M. Laffan,et al.  Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs*10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype. , 2020, Thrombosis research.

[9]  Eun-Ju Lee,et al.  Management of pregnancy in women with factor VII deficiency: A case series , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  A. Harroche,et al.  Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency. , 2020, Thrombosis research.

[11]  S. Balen,et al.  Factor X Deficiency Management for Elective Cesarean Delivery in a Pregnant Patient , 2020, The American journal of case reports.

[12]  A. Shapiro.  The use of prophylaxis in the treatment of rare bleeding disorders. , 2020, Thrombosis research.

[13]  Wenman Wu,et al.  Low Factor V level Ameliorates Bleeding Diathesis in Patients with Combined Deficiency of Factor V and Factor VIII. , 2019, Blood.

[14]  J. Bussel,et al.  Peri- and Postpartum Management of Patients With Factor XI Deficiency , 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[15]  K. Robinson.  An overview of inherited factor VII deficiency. , 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[16]  S. Meunier,et al.  Benefits of thromboelastometry for monitoring replacement therapy in patients with severe inherited factor XIII deficiency: 3 illustrative cases , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  M. Safa,et al.  A Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency , 2019, Seminars in Thrombosis and Hemostasis.

[18]  J. Amiral,et al.  The contact system at the crossroads of various key patho- physiological functions: Update on present understanding, laboratory exploration and future perspectives. , 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[19]  T. Lambert,et al.  Clinical pharmacology, efficacy and safety study of a triple‐secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency , 2019, Journal of thrombosis and haemostasis : JTH.

[20]  R. Kadir,et al.  Congenital Factor X deficiency in women: A systematic review of the literature , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  D. O’Keeffe,et al.  Management of combined factor V and factor VIII deficiency in pregnancy , 2019, Journal of Obstetrics and Gynaecology Research.

[22]  F. Peyvandi,et al.  Treatment of rare factor deficiencies other than hemophilia. , 2019, Blood.

[23]  S. Acharya,et al.  Management of rare coagulation disorders in 2018. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[24]  R. Liesner,et al.  Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high‐purity plasma‐derived factor X (pdFX) concentrate , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  P. Simioni,et al.  “In vitro” correction of the severe factor V deficiency‐related coagulopathy by a novel plasma‐derived factor V concentrate , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[26]  M. Nijziel,et al.  Hemorrhagic disorders of fibrinolysis: a clinical review , 2018, Journal of thrombosis and haemostasis : JTH.

[27]  S. Krassova,et al.  Major and Minor Classifications for Surgery in People With Hemophilia: A Literature Review , 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[28]  M. Karimi,et al.  Successful delivery in an patient with afibrinogenemia after three abortions: A case report and review of the literature , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[29]  M. Franchini,et al.  Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia , 2017, Seminars in Thrombosis and Hemostasis.

[30]  P. Bucciarelli,et al.  Minimal factor XIII activity level to prevent major spontaneous bleeds , 2017, Journal of thrombosis and haemostasis : JTH.

[31]  D. Niederwieser,et al.  Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy. , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  B. Kerlin,et al.  Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII‐A deficiency: international phase 3b trial results , 2017, Journal of thrombosis and haemostasis : JTH.

[33]  D. Stockton,et al.  Factor VII and factor X deficiency in a child with a chromosome 13q duplication and deletion , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[34]  A. Dorgalaleh,et al.  Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran , 2017, Hematology.

[35]  C. Howard,et al.  Combined deficiency of factor V and factor VIII: management during cardiothoracic surgery , 2017, Blood Coagulation and Fibrinolysis.

[36]  O. Vanakker,et al.  GGCX-Associated Phenotypes: An Overview in Search of Genotype-Phenotype Correlations , 2017, International journal of molecular sciences.

[37]  A. Shapiro.  Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety , 2017, Expert opinion on drug metabolism & toxicology.

[38]  Dana Shani,et al.  A case of congenital prothrombin deficiency and idiopathic thrombocytopenic purpura in a pregnant female. , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[39]  F. Peyvandi,et al.  Treatment of rare factor deficiencies in 2016. , 2016, Hematology. American Society of Hematology. Education Program.

[40]  A. Casini,et al.  Management of congenital quantitative fibrinogen disorders: a Delphi consensus , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[41]  James N. Huang,et al.  Experience of a new high‐purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[42]  J. Corral,et al.  Uniparental disomy causes deficiencies of vitamin K‐dependent proteins , 2016, Journal of thrombosis and haemostasis : JTH.

[43]  A. Casini,et al.  Can the phenotype of inherited fibrinogen disorders be predicted? , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[44]  N. Kanayama,et al.  Three successful deliveries involving a woman with congenital afibrinogenaemia – conventional fibrinogen concentrate infusion vs. ‘as required’ fibrinogen concentrate infusion based on changes in fibrinogen clearance – , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[45]  A. Chuansumrit,et al.  Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[46]  A. Shapiro,et al.  Pharmacokinetics of a high‐purity plasma‐derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[47]  A. Shapiro,et al.  Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in subjects with hereditary factor X deficiency , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[48]  K. Meijer,et al.  Gynaecological and obstetrical bleeding in women with factor XI deficiency – a systematic review , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[49]  C. Vézina,et al.  Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[50]  A. Shirdel,et al.  Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial , 2016, Journal of thrombosis and haemostasis : JTH.

[51]  M. Lee,et al.  Factor V Deficiency in Korean Patients: Clinical and Laboratory Features, Treatment, and Outcome , 2016, Journal of Korean medical science.

[52]  C. Négrier,et al.  Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation , 2015, British journal of haematology.

[53]  F. Peyvandi,et al.  Long‐term prophylaxis in severe factor VII deficiency , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[54]  A. Guarini,et al.  Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[55]  A. Casini,et al.  Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management , 2015, Journal of thrombosis and haemostasis : JTH.

[56]  A. Shapiro,et al.  Rare bleeding disorders: diagnosis and treatment. , 2015, Blood.

[57]  P. Chamouni,et al.  Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[58]  H. Hemker,et al.  Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation. , 2015, Blood.

[59]  A. Dorgalaleh,et al.  Factor XIII Deficiency in Iran: A Comprehensive Review of the Literature , 2015, Seminars in Thrombosis & Hemostasis.

[60]  A. Lebreton,et al.  Natural history of patients with congenital dysfibrinogenemia. , 2015, Blood.

[61]  A. Lebreton,et al.  Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[62]  C. Leissinger,et al.  Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures , 2015, Transfusion.

[63]  A. Mangione,et al.  Efficacy and safety of prophylactic treatment with plasma‐derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[64]  J. Huntington,et al.  A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop). , 2014, Blood.

[65]  A. Dorgalaleh,et al.  RARE BLEEDING DISORDERS: A NARRATIVE REVIEW OF EPIDEMIOLOGY, MOLECULAR AND CLINICAL PRESENTATIONS, DIAGNOSIS AND TREATMENT , 2014 .

[66]  C. Hermans,et al.  FXI concentrate use and risk of thrombosis , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[67]  L. Ardillon,et al.  Management of bleeding in severe factor V deficiency with a factor V inhibitor , 2014, Vox sanguinis.

[68]  G. Mariani,et al.  Invasive procedures and minor surgery in factor VII deficiency , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[69]  F. Rosendaal,et al.  Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders , 2012, Journal of thrombosis and haemostasis : JTH.

[70]  R. Kalil,et al.  Factor X deficiency and pregnancy: case report and counselling , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[71]  J. Schved,et al.  A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII‐deficient patients , 2011, Journal of thrombosis and haemostasis : JTH.

[72]  G. Mariani,et al.  Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STER , 2011, British journal of haematology.

[73]  G. Mariani,et al.  Effective Hemostasis During Minor Surgery in a Case of Hereditary Combined Deficiency of Vitamin K-dependent Clotting Factors , 2010, Clinical and applied thrombosis/hemostasis.

[74]  D. Perry,et al.  A review of long‐term prophylaxis in the rare inherited coagulation factor deficiencies , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[75]  S. L. Carpenter,et al.  α2‐Antiplasmin and its deficiency: fibrinolysis out of balance , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[76]  F. Rodeghiero.  Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin , 2007, Haemophilia.

[77]  F. Rosendaal,et al.  Coagulation factor activity and clinical bleeding severity in rare bleeding disorders : results from the European Network of Rare Bleeding Disorders , 2011 .

[78]  D. Perry,et al.  Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[79]  A. Batorova,et al.  Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[80]  P. Mannucci,et al.  Recessively inherited coagulation disorders. , 2004, Blood.

[81]  A. Pourfathollah,et al.  Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north‐eastern Iran , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[82]  P. Kouides,et al.  Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[83]  R. Favier,et al.  Congenital alpha(2)-plasmin inhibitor deficiencies: a review. , 2001, British journal of haematology.

[84]  G. Mariani,et al.  Use of Recombinant, Activated Factor VII in the Treatment of Congenital Factor VII Deficiencies , 1999, Vox Sanguinis.

[85]  D. Perry.  Factor X and its deficiency states , 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

[86]  M. Shearer,et al.  Mechanism of Cephalosporin‐induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status , 1988, Journal of clinical pharmacology.

[87]  A. Zivelin,et al.  Combined Factor V and Factor VIII Deficiency among Non‐Ashkenazi Jews , 1983, The New England journal of medicine.

[88]  S. Lewis.  British Committee for Standards in Haematology , 1969 .